1．廖二元，超楚生．内分泌学．北京:人民卫生出版社，2001．

2．罗敏．分子内分泌学:基础与临床．北京:人民军医出版社，2003．

3．姚泰．人体生理学．第3版．北京:人民卫生出版社，2001．

4．王一飞．人类生殖生物学．上海:科学技术文献出版社，2005．

5．迟素敏．内分泌生理学．西安:第四军医大学出版社，2006．

6．于传鑫，李诵弦．实用妇科内分泌学．第2版．上海:复旦大学出版社，2006．

7．刘新民，潘长玉，张达青，等．实用内分泌学．第3版．北京:人民军医出版社，2004．

8．陈加伦．世纪之交的内分泌学浅谈(上)．中华内分泌代谢杂志，2000，16( 6) : 337-341．

9．陈加伦．胰岛素信号转导及临床意义(上)．国外医学内分泌学分册，2002，22( 1) : 1-4．

10．陈晓萍，徐远扬．神经、内分泌、免疫网络的通用生物学语言．自然杂志，2002，24( 4) : 194-197．

11．冯绮文，苏青．甲状腺激素受体研究进展．国外医学内分泌学分册，2003，23( 1) : 44-46．

12．董凌燕．胰岛β细胞功能的调节．国外医学内分泌学分册，2003，23( B04) : 26-28．

13．杨权．下丘脑-垂体-肾上腺皮质轴应激反应的中枢控制．生理科学进展，2000，31( 3) : 222-226．

14．姚晓．催乳素释放肽的研究进展．国外医学内分泌学分册，2003，23( B04) : 57-59．

15．Strauss JF，Barbieri RL．Yen and Jaffe’s reproductive endocrinology: physiology，pathophysiology and clinical management．5th ed．Philadelphia: Elsevier Saunders，2004．

16．Klaassen CD．Casarett and Doull’s Toxicology: the basic science of poisons．6th ed．New York: McGraw-Hill Companies，Inc．，2001．

17．Gardner DG，Shoback DM．Greenspan’s basic and clinical endocrinology．8th ed．New York: McGraw-Hill Companies，Inc．，2007．

18．Greenspan SF，Gardner DG．Basicand clinical endocrinology．6th ed．New York: McGraw-Hill Companies，Inc．，2001．

19．Griffin JE，Ojeda SR．Textbook ofendocrine physiology．5th ed．Oxford: Oxford University Press Inc．，2004．

20．Harmel AP，Mathur R．Davidson’s diabetes mellitus: diagnosis and treatment．5th ed．Philadelphia: Elsevier Saunders，2004．

21．Jameson JL，Kasper DL，Fauci AS，et al．Harrison’s endocrinology．New York: McGraw-Hill Companies，Inc．，2006．

22．Kacsoh B．Endocrine physiology．New York: McGraw-Hill Companies，2000．

23．Larsen PR，Kronenberg HM，Melmed S，et al．Williams textbook of endocrinology．10th ed．Philadelphia: Elsevier Saunders，2002．

24．Murray RK，Granner DK，Mayers PA，et al．Harper’s illustrated biochemistry．26th ed．New York: McGraw-Hill Companies，Inc．，2003．

25．Porterfield SP．Endocrinephysiology．2nd ed．St Louis，MO: Mosby，Inc．，2001．

26．Kashyap SR，Defronzo RA．The insulin resistance syndrome: physiological considerations．Diab Vasc Dis Res，2007，4( 1) : 13-19．

27．Yen PM．Physiological and molecular basis of thyroid hormone action．Physiol Rev，2001，81( 3) : 1097-1142．

28．Szkudlinski MW，Fremont V，Ronin C，et al．Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure functionrelationships．Physiol Rev，2002，82( 2) : 473-502．

29．Spt A，Hunyady L．Control of aldosterone secretion: a model for convergence in cellular signaling pathways．Physiol Rev，2004，84( 2) : 489-539．

30．Becker KL，Bilezikian JP，Bremner WJ，et al．Principles and practice of endocrinology and metabolism．3rd ed．Philadelphia: Lippincott Williams＆Wilkins，2001．

31．Alison RH，Capen CC，Prentice DE．Neoplastic lesions of questionable significance to humans．Toxicol Pathol，1994，22( 2) : 179-186．

32．Davies TS，Monro A．Marketed human pharmaceuticals reported to be tumorigenic in rodents．J Am Coll Toxicol，1995，14( 2) : 90-107．

33．Thurman JD，Bucci TJ，Hart RW，et al．Survival，body weight，and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats．Toxicol Pathol，1994，22( 1) : 1-9．

34．Capen CC．Correlation of mechanistic date and histopathology in the evaluation of selected toxic endpoints of the endocrine system．Toxicol Lett，1998，102-103: 405-409．

35．Brown WR，Fetter AD，Van Ryzin RJ，et al．Proliferative pituitary lesions in rats treated with salmon or porcine calcitonin．Toxicol Pathol，1993，21( 1) : 81-86．

36．Satoh H，Kajimura T，Chen CJ，et al．Invasive pituitary tumors in female F344 rats induced by estradiol dipropionate．Toxicol Pathol，1997，25( 5) : 462-469．

37．Gunnison AF，Bowers A，Nadziejko C，et al．Modulation of the inflammatory effects of inhaled ozone in rats by subcutaneous prolactin-secreting，pituitary-derived tumors．Fundam Appl toxicol，1997，37( 1) : 88-94．

38．Pickering CE，Pickering RG．The effect of repeated reproduction on the incidence of pituitary tumous in Wistar rats．Lab Anim，1984，18( 4) : 371-378．

39．Yamagami T，Handa H，Takeuchi J，et al．Rat pituitary adenoma and hyperplasia induced by caffeine administration．Surg Neurol，1983，20( 4) : 323-331．

40．Colby HD．Adrenal gland toxicity: chemically induced dysfunction．J Am Coll Toxicol，1988，7( 1) : 45-69．

41．Dominick MA，McGuire EJ，Reindel JF，et al．Subacute toxicity of a novel inhibitor of acyl-CoA: cholesterol acyltransferase in beagle dogs．Fundam Appl Toxicol，1993，20( 2) : 217-224．

42．Latendresse JR，Brooks CL，Capen CC．Toxic effects of butylated triphenyl phosphate-based hydraulic fluid and tricresyl phosphate in female F334 rats．Vet Pathol，1995，32( 4) : 394-402．

43．Yarrington JT，Loudy DE，Sprinkle DJ，et al．Degeneration of the rat and canine adrenal cortex caused by alpha-( 1，4-dioxido-3-methylquinoxalin-2-yl) -N-methylnitrone ( DMNM)．Fundam Appl Toxicol，1985，5 ( 2) : 370-381．

44．Baer A．Sugars and adrenomedullary proliferative lesions: the effects of lactose and various polyalcohols．J Am Coll Toxicol，1988，7( 1) : 71-81．

45．Mosher AH，Kircher CH．Proliferative lesions of the adrenal medulla in rats treated with Zomepirac sodium．J Am Coll Toxicol，1988，7( 1) : 83-93．

46．Tischler AS，Powers JF，Pignatello M，et al．Vitamin D3-induced proliferative lesions in the rats adrenal medulla．Toxicol Sci，1999，51( 1) : 9-18．

47．Warren S，Grozdev L，Gates O，et al．Radiation induced adrenal medullary tumors in the rat．Arch Pathol，1966，82( 2) : 115-118．

48．Capen C，Sagartz J．A ret transgenic mouse model of thyroid carcinogenesis．Lab Anim Sci，1998，48( 6) : 580-583．

49．Axelrad AA，Leblond CP: Induction of thyroid tumors in rats by low iodine diet．Cancer，1955，8( 2) : 339-367．

50．Capen CC．Mechanistic date and risk assessment of selected toxic end points of the thyroid gland．Toxic Pathol，1997，25( 1) : 39-48．

51．Curran PG，DeGroot LJ．The effects of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland．Endocr Rev，1991，12( 2) : 135-150．

52．Clements FW．The relationship of thyrotoxicosis and carcinoma of thyroid to endemic goiter．Med J Aust，1954，2 ( 23) : 894-897．

53．Clemmesen J，Fuglsang-Frederiksen V，Plum CM．Are anticonvulsants oncogenic? Lancet，1974，303( 7860) : 705-707．

54．Copp DH．Endocrine regulation of calcium metabolism．Annu Rev Physiol，1970，32: 61-86．

55．Friedman GD．Barbiturates and lung cancer in humans．J Natl Cancer Inst，1982，67( 2) : 291-295．

56．Hill RN，Crisp TM，Hurley PM，et al．Risk assessment of thyroid follicular cell tumors．Environ Health Perspect，1998，106( 8) : 447-457．

57．Ingbar SH．Autoregulation of the thyroid．Response to iodide excess and depletion．Mayo Clin Proc，1972，47 ( 11) : 814-823．

58．Lamm SH，Doemland M．Has perchlorate in drinking water increased the rate of congenital hypothyroidism? J Occup Environ Med，1999，41( 5) : 409-411．

59．Li Z，Li FX，Byrd D，et al．Neonatal thyroxine level and perchlorate in drinking water．J Occup Environ Med，2000，42( 2) : 200-205．

60．Morris HP．The experimental development and metabolism of thyroid gland tumors．Adv Cancer Res，1955，3: 51-115．

61．Ohshima M，Ward JM．Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCr rats．Cancer Res，1986，46( 2) : 877-883．

62．Poirier LA，Doerge DR，Gaylor DW，et al．An FDA review of sulfamethazine toxicity．Regul Toxicol Pharmacol，1999，30( 3) : 217-222．

63．Spitzweg C，Heufelder AE，Morris JC．Thyroid iodine transport．Thyroid，2000，10( 4) : 321-330．

64．Zbinden G．Hyperplastic and neoplastic responses of the thyroid gland in toxicological studies．Arch Toxicol，1988，Suppl 12: 98-106．

65．Atwal OS，Wilson T．Parathyroid gland changes following ozone inhalation: a morphologic study．Arch Environ Health，1974，28( 2) : 91-100．

66．Brown EM．PTH secretion in vivo and in vitro．Regulation by calcium and other secretagogues．Miner Electrolyte Metab，1982，8( 3-4) : 130-150．

67．Habener JF．Recent advances in parathyroid hormone research．Clin Biochem，1981，14( 5) : 223-229．

68．Kalu DN，Hardin RR，Murata I，et al．Age-dependent modulation of parathyroid hormone action．Age，1982，5 ( 1) : 25-29．

69．Lupulescu A，Potorac E，Pop A．Experimental investigation on immunology of the parathyroid gland．Immunology，1968，14( 4) : 475-482．

70．Morrissey J，Rothstein M，Mayor G，et al．Suppression of parathyroid hormone secretion by aluminum．Kideny Int，1983，23( 5) : 699-704．

71．Morrissey J，Slatopolsky E．Effect of aluminum on parathyroid hormone secretion．Kideny Int Suppl，1986，18: S41-44．

72．Oettgen HF，Stephenson PA，Schwartz MK，et al．Toxicity of E．coli L-asparaginase in man．Cancer，1970，25( 2) : 253-278．

73．Br A．Significance of Leydig cell neoplasia in rats fed lactitol or lactose．J Am Coll Toxicol，1992，11( 2) : 189-207．

74．Clegg ED，Cook JC，Chapin RE，et al．Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans．Reprod Toxicol，1997，11( 1) : 107-121．

75．Murakami M，Hosokawa S，Yamada T，et al．Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone．Toxicol Appl Pharmacol，1995，131( 2) : 244-252．

76．Alison RH，Morgan KT．Ovarian neoplasms in F344 rats and B6C3F1 mice．Environ health Perspect，1987，73: 91-106．

77．Capen CC，Beamer WG，Tennent BJ，et al．Mechanisms of hormone-mediated carcinogenesis of the ovary in mice．Mutat Res，1995，333( 1-2) : 143-151．

78．Guthrie MJ．Tumorigenesis in intrasplenic ovaries in mice．Cancer，1957，10( 1) : 190-203．

79．Hart JE．Endocrine pathology of estrogens: species differences．Pharmacol Ther，1997，47( 2) : 203-218．